Unknown

Dataset Information

0

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.


ABSTRACT: BACKGROUND:Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms. AIMS:This pilot dose response trial assessed efficacy and safety of MDMA-assisted psychotherapy across multiple therapy teams. METHODS:Twenty-eight people with chronic posttraumatic stress disorder were randomized in a double-blind dose response comparison of two active doses (100 and 125 mg) with a low dose (40 mg) of MDMA administered during eight-hour psychotherapy sessions. Change in the Clinician-Administered PTSD Scale total scores one month after two sessions of MDMA served as the primary outcome. Active dose groups had one additional open-label session; the low dose group crossed over for three open-label active dose sessions. A 12-month follow-up assessment occurred after the final MDMA session. RESULTS:In the intent-to-treat set, the active groups had the largest reduction in Clinician-Administered PTSD Scale total scores at the primary endpoint, with mean (standard deviation) changes of -26.3 (29.5) for 125 mg, -24.4 (24.2) for 100 mg, and -11.5 (21.2) for 40 mg, though statistical significance was reached only in the per protocol set ( p=0.03). Posttraumatic stress disorder symptoms remained lower than baseline at 12-month follow-up ( p<0.001) with 76% ( n=25) not meeting posttraumatic stress disorder criteria. There were no drug-related serious adverse events, and the treatment was well-tolerated. CONCLUSIONS:Our findings support previous investigations of MDMA-assisted psychotherapy as an innovative, efficacious treatment for posttraumatic stress disorder.

SUBMITTER: Ot'alora G M 

PROVIDER: S-EPMC6247454 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Ot'alora G Marcela M   Grigsby Jim J   Poulter Bruce B   Van Derveer Joseph W JW   Giron Sara Gael SG   Jerome Lisa L   Feduccia Allison A AA   Hamilton Scott S   Yazar-Klosinski Berra B   Emerson Amy A   Mithoefer Michael C MC   Doblin Rick R  

Journal of psychopharmacology (Oxford, England) 20181029 12


<h4>Background</h4>Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms.<h4>Aims</h4>This pilot dose response trial assessed efficacy and safety of MDMA-assisted psychotherapy across multiple therapy teams.<h4>Methods</h4>Twenty-eight people with chronic posttraumatic stress disorder were rand  ...[more]

Similar Datasets

| S-EPMC6435835 | biostudies-literature
| S-EPMC7216948 | biostudies-literature
| S-EPMC5917000 | biostudies-literature
| S-EPMC4674381 | biostudies-literature
| S-EPMC8453707 | biostudies-literature
| S-EPMC3573678 | biostudies-literature
| S-EPMC10769553 | biostudies-literature
| S-EPMC8155739 | biostudies-literature
| S-EPMC5542864 | biostudies-literature
| S-EPMC5788122 | biostudies-literature